Use of Proton Pump Inhibitors and Histamine Type 2 Receptor Blockers Is Not Associated with Pneumonia Risk

被引:0
作者
Dublin, Sascha [1 ,2 ]
Walker, Rod L. [1 ]
Jackson, Michael L. [1 ]
Nelson, Jennifer C. [1 ,3 ]
Weiss, Noel S. [2 ]
Jackson, Lisa A. [1 ,2 ]
机构
[1] Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA
[2] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA
[3] Univ Washington, Dept Biostat, Seattle, WA 98195 USA
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
引用
收藏
页码:S18 / S19
页数:2
相关论文
共 50 条
[21]   Risk of clostridium difficile infection associated with used of proton pump inhibitors and histamine-2 receptor antagonists in Taiwan hospitalized patients [J].
Liu, Yi Hsuan ;
Yang, Yea-Huei Kao ;
Wu, Lu Hsuan ;
Su, Chien-Chou .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 :273-273
[22]   Use of Proton Pump Inhibitors vs Histamine 2 Receptor Antagonists for the Risk of Gastric Cancer: Population-Based Cohort Study [J].
Shin, Ga-Yeong ;
Park, Jae Myung ;
Hong, Jinhyuk ;
Cho, Yu Kyung ;
Yim, Hyeon Woo ;
Choi, Myung-Gyu .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 (06) :1211-1219
[23]   Use of proton pump inhibitors and histamine-2 receptor antagonists and risk of gastric cancer in two population-based studies [J].
Liu, Peipei ;
McMenamin, Una C. ;
Johnston, Brian T. ;
Murchie, Peter ;
Iversen, Lisa ;
Lee, Amanda J. ;
Vissers, Pauline A. J. ;
Cardwell, Chris R. .
BRITISH JOURNAL OF CANCER, 2020, 123 (02) :307-315
[24]   Use of proton pump inhibitors and histamine-2 receptor antagonists and risk of gastric cancer in two population-based studies [J].
Liu, Peipei ;
McMenamin, Una ;
Johnston, Brian ;
Murchie, Peter ;
Iversen, Lisa ;
Lee, Amanda ;
Vissers, Pauline ;
Cardwell, Christopher .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 :45-45
[25]   Use of proton pump inhibitors and histamine-2 receptor antagonists and risk of gastric cancer in two population-based studies [J].
Peipei Liu ;
Úna C. McMenamin ;
Brian T. Johnston ;
Peter Murchie ;
Lisa Iversen ;
Amanda J. Lee ;
Pauline A. J. Vissers ;
Chris R. Cardwell .
British Journal of Cancer, 2020, 123 :307-315
[26]   Use of proton pump inhibitors and H2 blockers and risk of pneumonia in older adults: a population-based case-control study [J].
Dublin, Sascha ;
Walker, Rod L. ;
Jackson, Michael L. ;
Nelson, Jennifer C. ;
Weiss, Noel S. ;
Jackson, Lisa A. .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 (08) :792-802
[27]   Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture [J].
Vestergaard, P. ;
Rejnmark, L. ;
Mosekilde, L. .
CALCIFIED TISSUE INTERNATIONAL, 2006, 79 (02) :76-83
[28]   Proton Pump Inhibitors, Histamine H2 Receptor Antagonists, and Other Antacid Medications and the Risk of Fracture [J].
P. Vestergaard ;
L. Rejnmark ;
L. Mosekilde .
Calcified Tissue International, 2006, 79 :76-83
[29]   Proton pump inhibitors and chronic kidney disease risk: a comparative study with histamine-2 receptor antagonists [J].
Kweon, Takhyeon ;
Kim, Yerim ;
Lee, Kyung Joo ;
Seo, Won-Woo ;
Seo, Seung In ;
Shin, Woon Geon ;
Shin, Dong Ho .
SCIENTIFIC REPORTS, 2023, 13 (01)
[30]   Proton pump inhibitors and chronic kidney disease risk: a comparative study with histamine-2 receptor antagonists [J].
Takhyeon Kweon ;
Yerim Kim ;
Kyung Joo Lee ;
Won-Woo Seo ;
Seung In Seo ;
Woon Geon Shin ;
Dong Ho Shin .
Scientific Reports, 13 (1)